![Zealand and Beta Bio](/news-release/logo/356649/0/356649.jpg?lastModified=12%2F09%2F2016%2022%3A41%3A25&size=2)
Zealand and Beta Bionics to collaborate on the development of a first-in-class dual-hormonal bionic pancreas system for treatment of people with type 1 diabetes
June 10, 2016 09:00 ET
|
Zealand Pharma A/S
Synergistic match of Beta Bionics’s dual-hormonal, artificial, or bionic, pancreas device platform, the iLet, and Zealand’s novel liquid stable glucagon analog, ZP4207
An automated insulin +...
![Zealand og Beta Bion](/news-release/logo/356649/0/356649.jpg?lastModified=12%2F09%2F2016%2022%3A41%3A25&size=2)
Zealand og Beta Bionics i samarbejde om udviklingen af et banebrydende, bi-hormonelt bugspytkirtelsystem til behandling af type 1-diabetikere
June 10, 2016 09:00 ET
|
Zealand Pharma A/S
Et synergistisk match mellem Beta Bionics’ kunstige (eller bioniske), bi-hormonelle bugspytkirtelsystem, benævnt iLet, og Zealands nye, flydende og stabile glukagon-analog ZP4207
Et...
![Zealand informs of n](/news-release/logo/356649/0/356649.jpg?lastModified=12%2F09%2F2016%2022%3A41%3A25&size=2)
Zealand informs of new data on iGlarLixi and proprietary preclinical peptide drug candidates to be presented at the 76th Annual American Diabetes Associations Scientific Sessions
June 08, 2016 15:39 ET
|
Zealand Pharma A/S
First time presentations at a scientific congress of results from the two pivotal Phase III trials, LixiLan-L and LixiLan-O, with iGlarLixi
Presentations in two oral sessions on Sunday, 12...
![Zealand meddeler, at](/news-release/logo/356649/0/356649.jpg?lastModified=12%2F09%2F2016%2022%3A41%3A25&size=2)
Zealand meddeler, at der præsenteres nye data vedrørende iGlarLixi og selskabets egne prækliniske peptidbaserede lægemiddelkandidater på den amerikanske diabetesforenings (ADA) 76. videnskabelige kongres
June 08, 2016 15:39 ET
|
Zealand Pharma A/S
For første gang præsenteres resultater fra de to fase III-studier LixiLan-O og LixiLan-L med iGlarLixi på en videnskabelig kongres
To mundtlige præsentationer finder sted på sessioner søndag...
![Zealand announces in](/news-release/logo/356649/0/356649.jpg?lastModified=12%2F09%2F2016%2022%3A41%3A25&size=2)
Zealand announces information received from its major shareholder, Sunstone LSV Management A/S, and a related change to its Board of Directors
June 02, 2016 05:59 ET
|
Zealand Pharma A/S
A proposed voluntary liquidation of certain Sunstone managed funds during Q3 2016 will lead to the distribution of 13% of Zealand’s share capital to a broad group of institutional...
![Zealand meddeler om](/news-release/logo/356649/0/356649.jpg?lastModified=12%2F09%2F2016%2022%3A41%3A25&size=2)
Zealand meddeler om information modtaget fra storaktionær, Sunstone LSV Management A/S, og om en relateret ændring i bestyrelsen
June 02, 2016 05:59 ET
|
Zealand Pharma A/S
En foreslået, frivillig opløsning af visse fonde forvaltet af Sunstone medfører i 3. kvartal 2016, at 13% af Zealands aktiekapital vil blive fordelt til en bred gruppe af institutionelle...
![Zealand presents at](/news-release/logo/356649/0/356649.jpg?lastModified=12%2F09%2F2016%2022%3A41%3A25&size=2)
Zealand presents at international healthcare investor conferences in June 2016
June 01, 2016 15:46 ET
|
Zealand Pharma A/S
Copenhagen, 1 June 2016 – Zealand informs that its senior management will present the company and host investor meetings at the following healthcare investor conferences in June 2016, taking place...
![Zealand præsenterer](/news-release/logo/356649/0/356649.jpg?lastModified=12%2F09%2F2016%2022%3A41%3A25&size=2)
Zealand præsenterer på internationale healthcare−investorkonferencer i juni 2016
June 01, 2016 15:46 ET
|
Zealand Pharma A/S
København, 1. juni 2016 – Zealand meddeler, at selskabets ledelse vil præsentere selskabet og afholde investormøder ved følgende healthcare-investorkonferencer, der afholdes i juni 2016 i...
![Zealand annoncerer d](/news-release/logo/356649/0/356649.jpg?lastModified=12%2F09%2F2016%2022%3A41%3A25&size=2)
Zealand annoncerer det samlede antal aktier og stemmerettigheder i selskabet pr. 31. maj 2016
May 31, 2016 07:50 ET
|
Zealand Pharma A/S
København, 31. maj 2016 – I henhold til § 6 i Bekendtgørelse om udsteders oplysningsforpligtelser meddeler Zealand det samlede antal aktier og stemmerettigheder i selskabet ved udgangen af en...
![Zealand announces th](/news-release/logo/356649/0/356649.jpg?lastModified=12%2F09%2F2016%2022%3A41%3A25&size=2)
Zealand announces the total number of shares and voting rights in the company as of 31 May 2016
May 31, 2016 07:50 ET
|
Zealand Pharma A/S
Copenhagen, 31 May 2016 - In accordance with Section 6 of the Danish Statutory Order on Issuers' Disclosure Obligations, Zealand announces the total number of shares and voting rights in the company...